Armata Pharmaceuticals (ARMP) Accounts Payables (2016 - 2026)
Quarterly results put Accounts Payables at $1.4 million for Q1 2026, up 128.75% from a year ago — trailing twelve months through Mar 2026 was $1.4 million (up 128.75% YoY), and the annual figure for FY2025 was $1.7 million, down 17.03%.
Armata Pharmaceuticals has reported Accounts Payables over the past 14 years, most recently at $1.4 million for Q1 2026.
- Accounts Payables reached $1.4 million in Q1 2026 per ARMP's latest filing, down from $1.7 million in the prior quarter.
- Across five years, Accounts Payables topped out at $9.6 million in Q2 2023 and bottomed at $633000.0 in Q1 2025.
- Median Accounts Payables over the past 5 years was $2.1 million (2024), compared with a mean of $3.1 million.
- The largest annual shift saw Accounts Payables skyrocketed 430.23% in 2022 before it plummeted 85.28% in 2024.
- Over 5 years, Accounts Payables stood at $6.0 million in 2022, then tumbled by 82.05% to $1.1 million in 2023, then skyrocketed by 89.75% to $2.1 million in 2024, then dropped by 17.03% to $1.7 million in 2025, then decreased by 15.07% to $1.4 million in 2026.
- Business Quant data shows Accounts Payables for ARMP at $1.4 million in Q1 2026, $1.7 million in Q4 2025, and $1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 8.64 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 1.03 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.45 Mn |
| Dec 31, 2025 | 1.71 Mn |
| Sep 30, 2025 | 1.28 Mn |
| Jun 30, 2025 | 965,000.00 |
| Mar 31, 2025 | 633,000.00 |
| Dec 31, 2024 | 2.06 Mn |
| Sep 30, 2024 | 1.82 Mn |
| Jun 30, 2024 | 3.85 Mn |
| Mar 31, 2024 | 736,000.00 |
| Dec 31, 2023 | 1.08 Mn |
| Sep 30, 2023 | 6.70 Mn |
| Jun 30, 2023 | 9.58 Mn |
| Mar 31, 2023 | 5.00 Mn |
| Dec 31, 2022 | 6.03 Mn |
| Sep 30, 2022 | 2.98 Mn |
| Jun 30, 2022 | 4.02 Mn |
| Mar 31, 2022 | 3.44 Mn |
| Dec 31, 2021 | 1.14 Mn |
| Sep 30, 2021 | 1.81 Mn |
| Jun 30, 2021 | 2.30 Mn |
| Mar 31, 2021 | 1.76 Mn |
| Dec 31, 2020 | 1.93 Mn |
| Sep 30, 2020 | 1.87 Mn |
| Jun 30, 2020 | 1.50 Mn |
| Mar 31, 2020 | 1.45 Mn |
| Dec 31, 2019 | 731,000.00 |
| Sep 30, 2019 | 1.26 Mn |
| Jun 30, 2019 | 1.77 Mn |
| Mar 31, 2019 | 1.76 Mn |
| Dec 31, 2018 | 536,000.00 |
| Sep 30, 2018 | 714,000.00 |
| Jun 30, 2018 | 682,000.00 |
| Mar 31, 2018 | 810,000.00 |
| Dec 31, 2017 | 302,000.00 |
| Sep 30, 2017 | 949,000.00 |
| Jun 30, 2017 | 1.86 Mn |
| Mar 31, 2017 | 1.11 Mn |
| Dec 31, 2016 | 746,000.00 |
| Sep 30, 2016 | 2.17 Mn |
| Jun 30, 2016 | 2.24 Mn |